Durable Response to Durvalumab in Occult Small‐Cell Lung Cancer With Immune Checkpoint Inhibitor–Related Inflammatory Arthritis With Polymyalgia Rheumatica–Like Features
Geriatrics & Gerontology International · 2026
DOI: 10.1111/ggi.70678 ↗Kurz gefasst
Fallbericht in der Zeitschrift Geriatrics & Gerontology International, 2026. Verfasst von Akihito Fujimi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Sapporo Kiyota Hospital, Sapporo, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Antineoplastic Agents, Immunological, Arthritis, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
We report a case of occult small-cell lung cancer with durable disease control during durvalumab therapy for 51 months. The patient developed immune checkpoint inhibitor-related inflammatory arthritis with polymyalgia rheumatica-like features, highlighting diagnostic challenges and the importance of functional independence in older adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Sapporo Kiyota Hospital, Sapporo, Japan.
- Department of Rheumatology, Sapporo Kiyota Hospital, Sapporo, Japan.
- Department of Internal Medicine, Sapporo Kiyota Hospital, Sapporo, Japan.
- Department of Medical Oncology, Sapporo Medical University, Sapporo, Japan.
ORCID-Profile: Kohichi Takada
Zitieren
APA
Fujimi, A., Yamauchi, N., Sato, K., Nagamachi, Y., Nishisato, T., & Takada, K. (2026). Durable Response to Durvalumab in Occult Small‐Cell Lung Cancer With Immune Checkpoint Inhibitor–Related Inflammatory Arthritis With Polymyalgia Rheumatica–Like Features. Geriatrics & Gerontology International. https://doi.org/10.1111/ggi.70678
Vancouver
Fujimi A, Yamauchi N, Sato K, Nagamachi Y, Nishisato T, Takada K. Durable Response to Durvalumab in Occult Small‐Cell Lung Cancer With Immune Checkpoint Inhibitor–Related Inflammatory Arthritis With Polymyalgia Rheumatica–Like Features. Geriatrics & Gerontology International. 2026. doi:10.1111/ggi.70678
BibTeX
@article{Fujimi2026,
author = {Fujimi, Akihito and Yamauchi, Naofumi and Sato, Ken and Nagamachi, Yasuhiro and Nishisato, Takuji and Takada, Kohichi},
title = {Durable Response to Durvalumab in Occult Small‐Cell Lung Cancer With Immune Checkpoint Inhibitor–Related Inflammatory Arthritis With Polymyalgia Rheumatica–Like Features},
journal = {Geriatrics & Gerontology International},
year = {2026},
doi = {10.1111/ggi.70678}
}
EUVIMED